is glp 1 safe during breastfeeding Can You Take GLP-1s While Breastfeeding: Current Evidence Is it safe to use

and 503Bs have until March 19 to call it quits

Some patients experience constipation, which could theoretically increase intra-colonic pressure and potentially trigger diverticulitis symptoms, though there is no established clinical evidence directly linking these medications to diverticulitis flare-ups

GLP-1 Receptor Agonists Obesity Drugs Market Regional Analysis North America dominated the GLP-1 receptor agonists obesity drugs market with the largest revenue share of 55.56% in 2024, driven by high obesity prevalence, favorable reimbursement policies, and early adoption of innovative therapies such as semaglutide and tirzepatide Patients and providers in the region increasingly value the superior weight loss efficacy, cardiovascular benefits, and convenience of long-acting GLP-1 drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound), which have become key components in chronic weight and metabolic disorder management This widespread use is further supported by favorable reimbursement policies, high healthcare spending, and a proactive medical community, positioning North America as the leading hub for innovation and growth in the GLP-1 obesity drugs space U.S

This is the same mechanism behind any minor skin irritation, from a mosquito bite to a scratch

2023 [cited 2025 Mar 6]